Anhydrous Lactose & ANHYDROUS LACTOSE Excipient Use in Inhalation Dosage Forms

Anhydrous Lactose

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

9 Listed Products, 1 Microlex e.U, 1 DFE Pharma, 7 Kerry

REGULATORY FILINGS

11 Suppliers, 11 USDMF, 1 NDC API

SOLUTIONS BY APPLICATIONS

5 Fillers, Diluents & Binders, 2 Direct Compression, 2 Co-Processed Excipients, 1 Granulation

REF. STANDARDS & IMPURITIES

1 Others

1 Others

FINISHED FORMULATIONS

643 ORAL, 525 TABLET, 84 CAPSULE, 32 TABLET, EXTENDED RELEASE, 27 ORAL-28, 11 TABLET, DELAYED RELEASE, 6 POWDER, 5 CAPSULE, DELAYED REL PELLETS, 5 INTRAVENOUS, 5 SUBLINGUAL, 5 TABLET, CHEWABLE, 4 FOR SUSPENSION, 4 TABLET, ORALLY DISINTEGRATING, 3 INJECTABLE, 3 INJECTION, 3 SOLUTION, 1 CAPSULE, EXTENDED RELEASE, 1 FOR SUSPENSION, DELAYED RELEASE, 1 INHALATION, 1 ORAL-21, 1 TABLET, FOR SUSPENSION